Nice to see Access out there promoting prolindac-   this seems like a good play with all the big pharmas needing new oncology pipeline drugs-  they are going to have to buy them from companies like ACCESS!  Hope MuGArd sales start bringing in cash as soon as possible but looks like partnership with another pharma is a given in order for them to move forward aggressively with future trails of Prolindac